The therapeutic landscape for peritoneal carcinomatosis (PC) has witnessed an unprecedented transformation, evolving from a universally fatal diagnosis to a condition offering genuine treatment possibilities. This extraordinary shift demonstrates how cutting-edge surgical innovations, novel chemotherapeutic strategies, and advanced molecular understanding can revolutionize patient care....